| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2007 | CA2667445A1 Hiv-1 protease inhibitors |
| 01/04/2007 | CA2619503A1 Aromatase inhibitors for emergency contraception |
| 01/04/2007 | CA2613933A1 Methods and dosage forms for reducing side effects of carbamate compounds |
| 01/04/2007 | CA2613874A1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs |
| 01/04/2007 | CA2613748A1 Prostaglandin derivatives |
| 01/04/2007 | CA2613720A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | CA2613703A1 Abca1 elevating compounds |
| 01/04/2007 | CA2613647A1 Self-sterilizing products comprising a polymer bound to a phthalocyanine derivative |
| 01/04/2007 | CA2613632A1 Benzenoid ansamycin derivative |
| 01/04/2007 | CA2613631A1 Improved dosage forms for movement disorder treatment |
| 01/04/2007 | CA2613617A1 Compositions and methods for enhancement of sexual function |
| 01/04/2007 | CA2613607A1 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 01/04/2007 | CA2613545A1 Substituted n-cinnamyl benzamides |
| 01/04/2007 | CA2613522A1 Imidazole based lxr modulators |
| 01/04/2007 | CA2613517A1 Pyrazole based lxr modulators |
| 01/04/2007 | CA2613477A1 Thiol-sensitive positive inotropes |
| 01/04/2007 | CA2613407A1 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | CA2613403A1 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 01/04/2007 | CA2613389A1 Micogel topical formulations |
| 01/04/2007 | CA2613377A1 Alkyl sulfonamide derivatives |
| 01/04/2007 | CA2613354A1 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 01/04/2007 | CA2613326A1 P2y6 receptor agonists for treating lung diseases |
| 01/04/2007 | CA2613312A1 Phosphoramidate alkylator prodrugs |
| 01/04/2007 | CA2613273A1 Method for the treatment of acne |
| 01/04/2007 | CA2613221A1 Topical skin treating compositions |
| 01/04/2007 | CA2613162A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | CA2613107A1 Delayed release or extended-delayed release dosage forms of pramipexole |
| 01/04/2007 | CA2613102A1 Formulations of conjugated estrogens and bazedoxifene |
| 01/04/2007 | CA2613010A1 Fluoroprostaglandins nitroderivatives |
| 01/04/2007 | CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | CA2612917A1 Rapidly absorbing oral formulations of pde5 inhibitors |
| 01/04/2007 | CA2612885A1 Compositions and methods for treatment of cycle-related symptoms |
| 01/04/2007 | CA2612686A1 Benzopyranone compounds for treating cancer |
| 01/04/2007 | CA2612672A1 Treatment for sexual dysfunction |
| 01/04/2007 | CA2612623A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612619A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612614A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | CA2612601A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2612592A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | CA2612585A1 Anti-inflammatory aryl nitrile compounds |
| 01/04/2007 | CA2612573A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | CA2612552A1 Azaindazole compounds and methods of use |
| 01/04/2007 | CA2612478A1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 01/04/2007 | CA2612465A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | CA2612460A1 Chloro-substituted guanidines |
| 01/04/2007 | CA2612300A1 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 01/04/2007 | CA2612296A1 Snar process for preparing benzimidazole compounds |
| 01/04/2007 | CA2612008A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | CA2611953A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2611866A1 Treatment of occlusive thrombosis |
| 01/04/2007 | CA2611860A1 Compositions and methods of use of derivatized flavanols |
| 01/04/2007 | CA2611856A1 Inducing peripheral blood vessel vasodilation using polyphenols provided as cocoa |
| 01/04/2007 | CA2611849A1 Thermally-processed cocoa products useful for vascular health improvement |
| 01/04/2007 | CA2611639A1 4-fluoro-piperidine t-type calcium channel antagonists |
| 01/04/2007 | CA2611636A1 Methods and compositions containing natural folates for protecting against radiation damage |
| 01/04/2007 | CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | CA2611550A1 Hydroisoindoline tachykinin receptor antagonists |
| 01/04/2007 | CA2611296A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | CA2611153A1 3-fluoro-piperidine t-type calcium channel antagonists |
| 01/04/2007 | CA2611128A1 Novel indoline compounds |
| 01/04/2007 | CA2610978A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | CA2610805A1 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 01/04/2007 | CA2610484A1 Methods for the preparation of 9-deazapurine derivatives |
| 01/04/2007 | CA2610209A1 4-anilino-3-quinolinecarbonitriles for the treatment of cancer |
| 01/04/2007 | CA2610074A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | CA2609336A1 Quadraphasic continuous graduated estrogen contraceptive |
| 01/04/2007 | CA2609280A1 Antiviral compounds |
| 01/04/2007 | CA2608629A1 Orally disintegrating powder comprising cilostazol and mannitol |
| 01/04/2007 | CA2608476A1 Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells |
| 01/04/2007 | CA2606958A1 Synthesis of anastrozole and purification of one of its intermediate |
| 01/04/2007 | CA2606945A1 An impurity of anastrozole intermediate, and uses thereof |
| 01/04/2007 | CA2587344A1 Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants |
| 01/04/2007 | CA2583121A1 Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
| 01/04/2007 | CA2578108A1 Methods and compositions for inhibiting, destroying, and/or inactivating viruses |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739097A1 Hyaluronic acid/methotrexate compound |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739086A2 Pharmaceutical compositions of risperidone in aqueous solution |
| 01/03/2007 | EP1739083A1 Benzylidene-1,3-thiazolidine-2,4-dione compounds, uses thereof and compositions for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibres |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1739078A1 Antagonists of C5a-receptor |
| 01/03/2007 | EP1738772A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same |
| 01/03/2007 | EP1738771A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF |
| 01/03/2007 | EP1738768A1 Aqueous formulation for vecuronium bromide |
| 01/03/2007 | EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain |
| 01/03/2007 | EP1738761A1 Preventive and/or remedy for inflammatory bowel diseases |
| 01/03/2007 | EP1738760A1 Use of biocompatible amphiphilic polymers as an anti-inflammatory agent |
| 01/03/2007 | EP1738759A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
| 01/03/2007 | EP1738758A1 Antimicrobial combination of amine and oxygen compounds |
| 01/03/2007 | EP1738757A1 Prevention of secondary stroke with cholesterol lowering agents |
| 01/03/2007 | EP1738756A2 Esmolol formulation |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738753A2 New treatments using phenethylamine derivatives |
| 01/03/2007 | EP1738752A1 Pharmaceutical combinations comprising cis-retine acid |
| 01/03/2007 | EP1738751A2 Spaced drug delivery system |